Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 310

Similar articles for PubMed (Select 24819100)

1.

Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.

Yao YF, Du CZ, Chen N, Chen P, Gu J.

Dis Colon Rectum. 2014 May;57(5):602-7. doi: 10.1097/DCR.0000000000000107.

PMID:
24819100
2.

Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.

Wang L, Zhang XM, Li Z, Liu XJ, Chai J, Zhang GY, Cheng YF.

World J Gastroenterol. 2013 Oct 28;19(40):6876-82. doi: 10.3748/wjg.v19.i40.6876.

3.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

4.

Frequency of HER-2 positivity in rectal cancer and prognosis.

Conradi LC, Styczen H, Sprenger T, Wolff HA, Rödel C, Nietert M, Homayounfar K, Gaedcke J, Kitz J, Talaulicar R, Becker H, Ghadimi M, Middel P, Beissbarth T, Rüschoff J, Liersch T.

Am J Surg Pathol. 2013 Apr;37(4):522-31. doi: 10.1097/PAS.0b013e318272ff4d.

PMID:
23282976
5.

Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy.

Peng Y, Wang L, Du C, Gu J.

Int J Colorectal Dis. 2012 Dec;27(12):1555-60. doi: 10.1007/s00384-012-1485-8. Epub 2012 May 30.

PMID:
22645074
6.

Gender-related differences in pathological and clinical tumor response based on immunohistochemical proteins expression in rectal cancer patients treated with short course of preoperative radiotherapy.

Gasinska A, Adamczyk A, Niemiec J, Biesaga B, Darasz Z, Skolyszewski J.

J Gastrointest Surg. 2014 Jul;18(7):1306-18. doi: 10.1007/s11605-014-2526-0. Epub 2014 Apr 23.

PMID:
24756926
7.

p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.

Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P, Solomon MJ.

Dis Colon Rectum. 2003 Feb;46(2):192-202.

PMID:
12576893
9.

Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.

Schwandner O, Schlamp A, Broll R, Bruch HP.

Int J Colorectal Dis. 2007 Feb;22(2):127-36. Epub 2006 Aug 2.

PMID:
16896992
10.

Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.

Zhan T, Gu J, Li M, Du C.

Dis Colon Rectum. 2013 Apr;56(4):422-32. doi: 10.1097/DCR.0b013e31828576c6.

PMID:
23478609
11.

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.

Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77.

PMID:
15708244
12.

Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer.

Moon YW, Jeung HC, Rha SY, Choi YH, Yang WI, Chung HC.

Breast Cancer Res Treat. 2007 Jul;104(1):31-7. Epub 2007 Feb 15.

PMID:
17587181
13.
14.

Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?

Hur H, Kim NK, Min BS, Baik SH, Lee KY, Koom WS, Ahn JB, Kim H.

Dis Colon Rectum. 2014 May;57(5):592-601. doi: 10.1097/DCR.0000000000000109.

PMID:
24819099
15.

Rectal cancer: local recurrence after surgery without radiotherapy.

Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT.

Dis Colon Rectum. 2001 Mar;44(3):374-9.

PMID:
11289283
16.

Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.

Sprenger T, Conradi LC, Beissbarth T, Ermert H, Homayounfar K, Middel P, Rüschoff J, Wolff HA, Schüler P, Ghadimi BM, Rödel C, Becker H, Rödel F, Liersch T.

Cancer. 2013 Jan 1;119(1):26-35. doi: 10.1002/cncr.27703. Epub 2012 Jun 26.

17.

Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: association with response to neoadjuvant therapy and prognosis.

Meng X, Wang R, Huang Z, Zhang J, Feng R, Xu X, Zhu K, Dou X, Chen D, Yu J.

Cancer Sci. 2014 Jul;105(7):818-24. doi: 10.1111/cas.12421. Epub 2014 May 16.

PMID:
24730770
18.

Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.

Loftås P, Onnesjö S, Widegren E, Adell G, Kayed H, Kleeff J, Zentgraf H, Sun XF.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):137-42. doi: 10.1016/j.ijrobp.2008.10.076. Epub 2009 Mar 14.

PMID:
19289258
19.

Assessment of HER-2 status in pancreatic adenocarcinoma: correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival.

Saxby AJ, Nielsen A, Scarlett CJ, Clarkson A, Morey A, Gill A, Smith RC.

Am J Surg Pathol. 2005 Sep;29(9):1125-34.

PMID:
16096400
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk